Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,274.05 -131.61 (-0.34%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,152.52 +8.39 (+0.10%) Bitcoin USD
57,508.28 -3,601.64 (-5.89%) CMC Crypto 200
1,237.77 -101.30 (-7.56%)
Processa Pharmaceuticals, Inc. (PCSA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.25M |
| Enterprise value | 1.70M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.25 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.15 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.52 |
| 52-week change 3 | -83.48% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 18.0000 |
| 52-week low 3 | 1.4000 |
| 50-day moving average 3 | 2.1823 |
| 200-day moving average 3 | 5.9381 |
Share statistics
| Avg vol (3-month) 3 | 1.54M |
| Avg vol (10-day) 3 | 8.01M |
| Shares outstanding 5 | 2.86M |
| Implied shares outstanding 6 | 2.92M |
| Float 8 | 2.49M |
| % held by insiders 1 | 11.26% |
| % held by institutions 1 | 1.93% |
| Shares short (15 Apr 2024) 4 | 189.63k |
| Short ratio (15 Apr 2024) 4 | 0.46 |
| Short % of float (15 Apr 2024) 4 | 7.13% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.64% |
| Shares short (prior month 15 Mar 2024) 4 | 40.25k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 23 Dec 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 22 Jan 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -99.41% |
| Return on equity (ttm) | -178.52% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -11.46M |
| Net income avi to common (ttm) | -11.12M |
| Diluted EPS (ttm) | -8.4800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.71M |
| Total cash per share (mrq) | 1.65 |
| Total debt (mrq) | 150.55k |
| Total debt/equity (mrq) | 3.02% |
| Current ratio (mrq) | 7.71 |
| Book value per share (mrq) | 3.88 |
Cash flow statement
| Operating cash flow (ttm) | -8.06M |
| Levered free cash flow (ttm) | -4.11M |
© 2024 Yahoo. All rights reserved.